Merck Beats Profit Projections as Keytruda Sales Rise

Category: Business

Merck & Co. exceeded Wall Street profit estimates with adjusted earnings of $2.28 per share, driven by a 16% increase in Keytruda sales to $7.3 billion.

Keywords: Merck & Co., Keytruda, earnings report

Source: Bloomberg

Update At: 7/30/2024

Related Sources